Gut health boost: new supplement trial for dialysis patients
NCT ID NCT07461233
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is testing whether a 12-week course of a multi-species synbiotic (a mix of probiotics and prebiotics) can improve gut health and reduce harmful toxins in the blood of people on hemodialysis. The trial will enroll 30 adults who have been on dialysis for at least 3 months. Researchers will measure changes in gut bacteria, blood toxin levels, and markers of gut leakage.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC KIDNEY DISEASE are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Tungs' Taichung Metroharbour Hospital
RECRUITINGTaichung, Wuqi District, 435, Taiwan
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Aging kidneys under the microscope: could a simple test predict failure?
- Could early gut bacteria shape a Child's health? a 3-Year study seeks answers
- Can video games and electric pulses ease dialysis Patients' shoulder pain?
- Could your gut bacteria hold the key to protecting your kidneys?
- Food as medicine: could cooking classes slow kidney disease?
- Could a phone app be the key to managing kidney disease?